Summary
Philip Morris International Inc. (PM) reported a strong financial performance for the six months ended June 30, 2024. Net revenues increased by 7.5% to $18.3 billion, driven by a favorable pricing variance, particularly in combustible tobacco, and an increase in smoke-free product volume. Diluted Earnings Per Share (EPS) saw a significant increase of 27.5% to $2.92, boosted by higher operating income, favorable fair value adjustments on equity investments, and operational improvements across most segments, despite unfavorable currency impacts and higher amortization expenses. The company's strategic focus on smoke-free products continues to yield positive results, with smoke-free net revenues growing by 17.1% year-over-year for the six-month period. The Americas region, in particular, showed robust growth in oral smoke-free products, largely driven by the ZYN nicotine pouch brand. The company maintained strong cash flow from operations, generating $4.9 billion in the first six months, and ended the period with substantial liquidity available through committed credit facilities. Despite the positive financial results, PM faces ongoing challenges including regulatory scrutiny, inflationary pressures impacting costs, and potential impacts from geopolitical events. The company's proactive approach to managing these risks, coupled with its continued investment in smoke-free innovation and market expansion, positions it to navigate these challenges while pursuing long-term growth.
Financial Highlights
46 data points| Revenue | $9.47B |
| Cost of Revenue | $3.35B |
| Gross Profit | $6.12B |
| Operating Income | $3.44B |
| Net Income | $2.41B |
| EPS (Basic) | $1.54 |
| EPS (Diluted) | $1.54 |
| Shares Outstanding (Basic) | 1.55B |
| Shares Outstanding (Diluted) | 1.56B |
Key Highlights
- 1Net revenues for the six months ended June 30, 2024, increased by 7.5% to $18.3 billion, driven by favorable pricing and smoke-free product volume growth.
- 2Diluted EPS rose 27.5% to $2.92 for the six months ended June 30, 2024, compared to the prior year, reflecting strong operational performance and favorable equity investment adjustments.
- 3Smoke-free product net revenues saw a significant increase of 17.1% for the six months ended June 30, 2024, indicating continued success in the company's transformation strategy.
- 4The Americas region demonstrated strong growth, particularly in ZYN nicotine pouches, contributing significantly to oral smoke-free product volume.
- 5Net cash provided by operating activities was $4.9 billion for the first six months of 2024, demonstrating robust cash generation.
- 6The company ended the period with $6.2 billion in committed revolving credit facilities, and no outstanding borrowings under these facilities, indicating strong liquidity.
- 7Despite positive financial trends, the company faces ongoing risks related to regulatory changes, inflationary cost pressures, and geopolitical uncertainties.